[go: up one dir, main page]

PE20090274A1 - Compuestos triciclicos nitrogenados como agentes antibacterianos - Google Patents

Compuestos triciclicos nitrogenados como agentes antibacterianos

Info

Publication number
PE20090274A1
PE20090274A1 PE2008000682A PE2008000682A PE20090274A1 PE 20090274 A1 PE20090274 A1 PE 20090274A1 PE 2008000682 A PE2008000682 A PE 2008000682A PE 2008000682 A PE2008000682 A PE 2008000682A PE 20090274 A1 PE20090274 A1 PE 20090274A1
Authority
PE
Peru
Prior art keywords
alkyl
halogen
cr4r8
cyane
dihydro
Prior art date
Application number
PE2008000682A
Other languages
English (en)
Inventor
David Evan Davies
David Thomas Davies
Ilaria Giordano
Alan Joseph Hennessy
Neil David Pearson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39580226&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20090274(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0707705A external-priority patent/GB0707705D0/en
Priority claimed from GB0720569A external-priority patent/GB0720569D0/en
Priority claimed from GB0805311A external-priority patent/GB0805311D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20090274A1 publication Critical patent/PE20090274A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

REFERIDA A UN COMPUESTO TRICICLICO DE FORMULA (I), DONDE Z1 Y Z2 SON CH Y N; R1a Y R1b SON H, HALOGENO, CIANO, ALQUILO C1-C6, ENTRE OTROS; R2 ES H O ALQUILO C1-C4, ENTRE OTROS; A ES UN GRUPO (ia), (ib) O (ii); R3 ES H, HALOGENO, CIANO, ALQUILO C1-C6, ENTRE OTROS; n ES 1 O 2; W1, W2 Y W3 SON CR4R8 O W2 Y W3 SON CR4R8 Y W1 ES UN ENLACE ENTRE W3 Y N; X ES O, CR4R8 O NR6; R4 ES H,HALOGENO, CIANO, ALQUILO C1-C6, ENTRE OTROS; R8 ES H; R6 ES H O ALQUILO C1-C6; R7 ES H, HALOGENO, OH, ALQUILO C1-C6, ENTRE OTROS; U ES CO O CH2; R5 ES UN SISTEMA BICICLICO, CARBOCICLICO O HETEROCICLICO OPCIONALMENTE SUSTITUIDO CON UN GRUPO (B); X1 ES C, N O CR14; X2 ES N, NR13, O, CO, ENTRE OTROS; X3 Y X5 SON N O C; Y1 ES N, O, CO, ENTRE OTROS; Y2 ES N, O, CO, ENTRE OTROS; R14 ES H, HALO, ALQUILO C1-C4, ENTRE OTROS; R13 ES H, TRIFLUOROMETILO, ALQUILO C1-C4, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 1-({4-[(2,3-DIHIDRO[1,4]DIOXINO[2,3-c]PIRIDIN-7-ILMETIL)AMINO]-1-PIPERIDINIL}METIL)-1,2-DIHIDRO-3H,8H-2a,5,8a-TRIAZAACENAFTILENO-3,8-DIONA, 1-({4-[([1,3]OXATIOLO[5,4-c]PIRIDIN-6-ILMETIL)AMINO]-1-PIPERIDINIL}METIL)-1,2-DIHIDRO-4H,9H-IMIDAZO[1,2,3-j]-1,8-NAFTIRIDA-4,9-DIONA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS TIENEN ACTIVIDAD ANTIBACTERIANA Y SON UTILES EN EL TRATAMIENTO DE INFECCIONES DEL TRACTO RESPIRATORIO, DE LA PIEL, DEL TRACTO URINARIO, ENTRE OTROS
PE2008000682A 2007-04-20 2008-04-18 Compuestos triciclicos nitrogenados como agentes antibacterianos PE20090274A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0707705A GB0707705D0 (en) 2007-04-20 2007-04-20 Compounds
GB0720569A GB0720569D0 (en) 2007-10-19 2007-10-19 Compounds
GB0805311A GB0805311D0 (en) 2008-03-20 2008-03-20 Compounds

Publications (1)

Publication Number Publication Date
PE20090274A1 true PE20090274A1 (es) 2009-04-03

Family

ID=39580226

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000682A PE20090274A1 (es) 2007-04-20 2008-04-18 Compuestos triciclicos nitrogenados como agentes antibacterianos

Country Status (31)

Country Link
US (1) US8389524B2 (es)
EP (1) EP2137196B1 (es)
JP (1) JP5389013B2 (es)
KR (1) KR101567096B1 (es)
CN (1) CN101687887B (es)
AR (1) AR066111A1 (es)
AT (1) ATE483717T1 (es)
AU (1) AU2008240764C1 (es)
BR (1) BRPI0810064B8 (es)
CA (1) CA2684659C (es)
CL (1) CL2008001122A1 (es)
CO (1) CO6251368A2 (es)
CR (2) CR11123A (es)
CY (1) CY1111248T1 (es)
DE (1) DE602008002912D1 (es)
DK (1) DK2137196T3 (es)
DO (1) DOP2009000240A (es)
EA (1) EA015821B1 (es)
HR (1) HRP20100574T1 (es)
IL (1) IL201204A0 (es)
MA (1) MA31324B1 (es)
MX (1) MX2009011317A (es)
MY (1) MY149347A (es)
NZ (1) NZ579877A (es)
PE (1) PE20090274A1 (es)
PL (1) PL2137196T3 (es)
PT (1) PT2137196E (es)
SI (1) SI2137196T1 (es)
TW (1) TWI431006B (es)
UY (1) UY31038A1 (es)
WO (1) WO2008128942A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2340531T3 (es) * 2005-10-21 2010-06-04 Glaxo Group Limited Compuestos triciclos peri-condensados utiles como agentes antibacterianos.
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
US8486948B2 (en) 2007-10-19 2013-07-16 Boehringer Ingelheim International Gmbh Piperazinodihydrothienopyrimidine derivatives
RS52271B (sr) * 2007-10-19 2012-10-31 Boehringer Ingelheim International Gmbh Substituisani piperidino-dihidrotienopirimidin
KR20100075930A (ko) * 2007-10-19 2010-07-05 베링거 인겔하임 인터내셔날 게엠베하 헤테로사이클-치환된 피페라지노-디하이드로티에노피리미딘
CA2713182C (en) 2008-02-20 2016-09-13 Actelion Pharmaceuticals Ltd Azatricyclic antibiotic compounds
US20110071155A1 (en) * 2008-05-23 2011-03-24 Carlos Alemparte-Gallardo Tricyclic Nitrogen Containing Compounds And Their Use As Antibacterials
AU2009248786B2 (en) * 2008-05-23 2013-04-04 Glaxo Group Limited Tricyclic nitrogen containing compounds and their use as antibacterials
DK2344495T3 (en) 2008-10-07 2015-02-02 Actelion Pharmaceuticals Ltd TRICYCLIC OXAZOLIDINON ANTIBIOTIC COMPOUNDS
WO2010043714A1 (en) 2008-10-17 2010-04-22 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
JP2012515214A (ja) 2009-01-14 2012-07-05 トヘ サルク インストイトウテ フオル ビオルオギクアル ストウドイエス スクリーニング方法、及びアミロイド病に対し保護する化合物
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
TW201130854A (en) 2009-12-22 2011-09-16 Bayer Schering Pharma Ag Pyridinone derivatives and pharmaceutical compositions thereof
NZ603268A (en) * 2010-05-04 2015-02-27 Alkermes Pharma Ireland Ltd Process for synthesizing oxidized lactam compounds
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CN103113291B (zh) * 2013-02-04 2015-03-04 浙江大学 一种3位烯基吡啶衍生物的合成方法
JP6453216B2 (ja) * 2013-07-23 2019-01-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ縮合環化合物
SG11201700566SA (en) * 2014-08-22 2017-03-30 Glaxosmithkline Ip Dev Ltd Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
BR112018003417B1 (pt) * 2016-06-22 2023-10-24 Vanderbilt University Composto modulador alostérico positivo do receptor muscarínico de acetilcolina m4 e composição farmacêutica que o compreende
US11352349B2 (en) 2017-04-17 2022-06-07 Ohio State Innovation Foundation Type II topoisomerase inhibitors and methods of making and using thereof
EP3946342A1 (en) 2019-04-03 2022-02-09 GlaxoSmithKline Intellectual Property Development Limited Gepotidacin for use in the treatment of bacterial urinary tract infections
BR112021024845A2 (pt) * 2019-07-05 2022-01-18 Glaxosmithkline Ip Dev Ltd Combinação para o tratamento de infecções causadas por mycoplasma genitalium
EP4491231A3 (en) 2020-04-02 2025-04-09 Glaxosmithkline Intellectual Property Limited Regimen for treating a neisseria gonorrhoeae infection with gepotidacin
WO2021219637A1 (en) 2020-04-29 2021-11-04 Glaxosmithkline Intellectual Property Development Limited Crystalline forms of gepotidacin
CN111494241B (zh) * 2020-06-01 2023-03-24 湖北洁世达环保科技有限公司 一种纸巾柔润保湿液
WO2022167515A1 (en) 2021-02-05 2022-08-11 Glaxosmithkline Intellectual Property Development Limited Oral solid dose formulations
JP2025502442A (ja) 2022-01-21 2025-01-24 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ｓａｐｒｏｐｈｙｔｉｃｕｓによって引き起こされる感染症の処置における使用のためのゲポチダシンおよびバンコマイシン
EP4316463A1 (en) 2022-08-02 2024-02-07 GlaxoSmithKline Intellectual Property Development Limited Novel formulation
JP2025532252A (ja) 2022-09-26 2025-09-29 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド 処置方法

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403610B1 (en) 1999-09-17 2002-06-11 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
US6525049B2 (en) 2000-07-05 2003-02-25 Pharmacia & Upjohn Company Pyrroloquinolones as antiviral agents
US6624159B2 (en) * 2000-07-12 2003-09-23 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
HUP0300721A3 (en) 2000-07-26 2006-02-28 Smithkline Beecham Plc Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity, process for producing them, pharmaceutical compositions containing them and use thereof
US6603005B2 (en) 2000-11-15 2003-08-05 Aventis Pharma S.A. Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
GB0031088D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
AU2002219175A1 (en) 2000-12-21 2002-07-01 Ciba Speciality Chemicals Holding Inc. Crystalline forms of cerivastatin sodium
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
US6602884B2 (en) 2001-03-13 2003-08-05 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
WO2003048081A2 (en) 2001-12-04 2003-06-12 Bristol-Myers Squibb Company Glycinamides as factor xa inhibitors
JP4445753B2 (ja) 2002-01-29 2010-04-07 グラクソ グループ リミテッド アミノピペリジン誘導体
WO2003064431A2 (en) 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
GB0217294D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844268B1 (fr) 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
FR2844270B1 (fr) 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
JP4602903B2 (ja) 2002-10-10 2010-12-22 モルフォケム アクチェンゲゼルシャフト フュア コンビナトリシェ ヘミー 抗菌活性を有する新規化合物
EP1560821B8 (en) 2002-11-05 2010-05-19 Glaxo Group Limited Antibacterial agents
US7618959B2 (en) 2002-11-05 2009-11-17 Smithklinebeecham Corp Antibacterial agents
TW200427688A (en) 2002-12-18 2004-12-16 Glaxo Group Ltd Antibacterial agents
TW200507841A (en) 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
US7232833B2 (en) 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
DE10316081A1 (de) 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
US7348434B2 (en) 2003-08-08 2008-03-25 Antony Bigot 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2867472B1 (fr) 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
WO2006002047A2 (en) 2004-06-15 2006-01-05 Glaxo Group Limited Antibacterial agents
FR2872164B1 (fr) 2004-06-29 2006-11-17 Aventis Pharma Sa Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
EP1773831A1 (en) 2004-07-08 2007-04-18 Glaxo Group Limited Antibacterial agents
US20080194547A1 (en) 2004-07-09 2008-08-14 Glaxo Group Limited Antibacterial Agents
WO2006017326A1 (en) 2004-07-13 2006-02-16 Glaxo Group Limited Antibacterial agents
WO2006012396A1 (en) 2004-07-22 2006-02-02 Glaxo Group Limited Antibacterial agents
ATE484509T1 (de) 2004-08-02 2010-10-15 Glaxo Group Ltd Antibakterielle mittel
WO2006020561A2 (en) 2004-08-09 2006-02-23 Glaxo Group Limited Antibacterial agents
DE102004041163A1 (de) 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
CA2580621A1 (en) 2004-09-24 2006-03-30 Actelion Pharmaceuticals Ltd New bicyclic antibiotics
CN101039935B (zh) 2004-10-05 2011-04-20 埃科特莱茵药品有限公司 哌啶抗生素
JP5314244B2 (ja) 2004-10-27 2013-10-16 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
WO2006081289A2 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
EP1846416A4 (en) 2005-01-25 2009-07-01 Glaxo Group Ltd ANTIBACTERIAL AGENTS
JP2008528598A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
US7709472B2 (en) 2005-01-25 2010-05-04 Glaxo Group Limited Antibacterial agents
US7592334B2 (en) 2005-01-25 2009-09-22 Glaxo Group Limited Antibacterial agents
WO2006099884A1 (en) 2005-03-24 2006-09-28 Actelion Percurex Ag Beta-aminoalcohol antibiotics
CA2603322C (en) 2005-03-31 2014-12-16 Janssen Pharmaceutica N.V. Bicyclic pyrazole compounds as antibacterial agents
RU2007147413A (ru) 2005-05-24 2009-06-27 Астразенека Аб (Se) Аминопиперидинхинолины и их азаизостерические аналоги с антибактериальной активностью
CA2608687A1 (en) 2005-05-25 2006-11-30 Actelion Pharmaceuticals Ltd. New antibiotic derivatives
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
US8329694B2 (en) 2005-06-24 2012-12-11 Toyama Chemical Co., Ltd. Quinoxalinones as antibacterial composition
ES2340531T3 (es) 2005-10-21 2010-06-04 Glaxo Group Limited Compuestos triciclos peri-condensados utiles como agentes antibacterianos.
ES2344523T3 (es) 2005-12-22 2010-08-30 Glaxo Group Limited Compuestos heterociclicos, su preparacion y su uso como agentes antibacterianos.
WO2007115947A1 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
JP2009532504A (ja) 2006-04-06 2009-09-10 グラクソ グループ リミテッド 抗菌薬
GB0608263D0 (en) * 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
US20100256124A1 (en) 2006-06-09 2010-10-07 David Thomas Davies Substituted 1-Methyl-1H-Quinolin-2-Ones And 1-Methyl-1H-1,5-Naphthyridin-2-Ones As Antibacterials
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
GB0705672D0 (en) 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds
EP1980251A1 (en) 2007-04-13 2008-10-15 Glaxo Group Limited Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis
GB0707706D0 (en) 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
GB0707708D0 (en) 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
EP2005995A1 (en) 2007-06-22 2008-12-24 Glaxo Group Limited Heterocyclic compounds for the treatment of tuberculosis
GB0800367D0 (en) 2008-01-09 2008-02-20 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
MX2009011317A (es) 2009-11-05
DE602008002912D1 (de) 2010-11-18
CY1111248T1 (el) 2015-06-11
AU2008240764B2 (en) 2011-04-07
KR20100017133A (ko) 2010-02-16
JP2010524884A (ja) 2010-07-22
CR20150586A (es) 2016-04-04
AU2008240764C1 (en) 2011-10-20
TWI431006B (zh) 2014-03-21
HK1138000A1 (en) 2010-08-13
EA200970987A1 (ru) 2010-04-30
ATE483717T1 (de) 2010-10-15
PT2137196E (pt) 2010-12-16
BRPI0810064B1 (pt) 2021-03-30
CA2684659C (en) 2015-11-24
US8389524B2 (en) 2013-03-05
TW200848420A (en) 2008-12-16
EA015821B1 (ru) 2011-12-30
JP5389013B2 (ja) 2014-01-15
HRP20100574T1 (hr) 2010-12-31
DOP2009000240A (es) 2009-12-31
US20100137282A1 (en) 2010-06-03
NZ579877A (en) 2011-09-30
BRPI0810064A2 (pt) 2019-08-27
AU2008240764A1 (en) 2008-10-30
BRPI0810064B8 (pt) 2021-05-25
WO2008128942A1 (en) 2008-10-30
DK2137196T3 (da) 2011-01-10
CN101687887A (zh) 2010-03-31
CA2684659A1 (en) 2008-10-30
MA31324B1 (fr) 2010-04-01
IL201204A0 (en) 2010-05-17
CR11123A (es) 2010-03-08
UY31038A1 (es) 2008-11-28
EP2137196B1 (en) 2010-10-06
SI2137196T1 (sl) 2011-01-31
CO6251368A2 (es) 2011-02-21
PL2137196T3 (pl) 2011-03-31
AR066111A1 (es) 2009-07-22
CL2008001122A1 (es) 2008-10-24
KR101567096B1 (ko) 2015-11-06
EP2137196A1 (en) 2009-12-30
CN101687887B (zh) 2012-08-29
MY149347A (en) 2013-08-30

Similar Documents

Publication Publication Date Title
PE20090274A1 (es) Compuestos triciclicos nitrogenados como agentes antibacterianos
PE20070793A1 (es) Compuestos triciclicos que contienen nitrogeno como agentes antibacterianos
UY28885A1 (es) 4-fenilamino-quinazolin-6-il-amidas referencia cruzada a solicitud(es) relacionada(s)
PE20090648A1 (es) Compuestos para el tratamiento de la hepatitis c
PE20120413A1 (es) ENANTIOMERO (S) DE 1'-{[5-(TRIFLUOROMETIL)FURAN-2-IL]METIL}ESPIRO[FURO[2,3-f][1,3]BENZODIOXOL-7,3'-INDOL]-2'(1'H)-ONA
CR10383A (es) Derivados triazolopirazina.
SV2008002969A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
AR060287A1 (es) Compuesto de 5,6 dihidro-3h-pirrolo[1,2,3-de]quinoxalini-3-ona, su uso para preparar un medicamento, composicion farmaceutica que lo comprende y compuesto intermediario util para su preparacion
PA8591701A1 (es) Derivados de pirrolopirimidina
ECSP105253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
PE20141557A1 (es) Derivado de pirazoloquinolina
EA201690033A3 (ru) Морфинановые соединения
PE20120357A1 (es) Derivados de benzofurano
PE20080070A1 (es) Derivados de indolobenzazepina fusionados a ciclopropilo como inhibidores de la polimerasa ns5b del virus de la hepatitis c
NZ599815A (en) N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
IS8503A (is) Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar
PE20061397A1 (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos productos y metodos de preparacion
PE20121556A1 (es) 3,6-diazabiciclo[3.1.1]heptanos como ligandos de receptores nicotinicos neuronales de acetilcolina
MX2012004848A (es) Compuestos heterociclicos triciclicos.
NO20073776L (no) Trisykliske delta-opioidmodulatorer
PE20081837A1 (es) Derivados de quinuclinidol como antagonistas de los receptores muscarinicos
PE20090110A1 (es) Compuestos macrociclicos derivados de amina como agentes inhibidores de hsp90
AR058587A1 (es) Compuestos de pirrolo-1,5-naftiridinona,su uso como agentes antibacterianos, composiciones farmaceuticas que los contienen y compuestos intermediarios para preparar dichos compuestos
ATE486602T1 (de) Pyrrolo (3, 2, 1-ij) chinolin-4-on-derivate zur behandlung von tuberkulose
PE20090235A1 (es) Compuestos heterociclicos nitrogenados antibacterianos y su preparacion

Legal Events

Date Code Title Description
FG Grant, registration